Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research interests include Medicine, Cystic fibrosis, Pulmonary function testing, Ivacaftor, Exacerbation, and Pharmacokinetics.
An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2–5 years (KLIMB)
Decreased <i>Pseudomonas aeruginosa</i> detection in children after separation of pediatric from adult cystic fibrosis clinics: A single center experience
Objective Measurement of Adherence to Out-Patient Airway Clearance Therapy by High-Frequency Chest Wall Compression in Cystic Fibrosis
Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2–5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study
Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function
Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis
Pulmonary exacerbations in cystic fibrosis: Young children with characteristic signs and symptoms